Track topics on Twitter Track topics that are important to you
WAKEFIELD, Mass., June 8, 2015 (GLOBE NEWSWIRE) -- Comverse (Nasdaq:CNSI), a global leader in enabling innovative solutions for today's multi-device digital consumer, today announced that it has filed a Form 12B-25 with the Securities and Exchange Commission indicating that it will require up to an additional five days to report its financial results for the first fiscal quarter of 2015 ended April 30, 2015. Preparation of the quarterly report has been delayed by the Company's focus on its outsourcing transaction with Tech Mahindra Limited, and its agreement to sell its BSS business unit to Amdocs Limited, both announced late in the first quarter.
The company now intends to hold a conference call to review its first quarter results on Monday, June 15, 2015 at 8:00 am ET.
To listen to the conference call live, please dial (678) 825-8369. Please dial-in at least ten minutes before the scheduled start time. A live webcast can be accessed at www.comverse.com by following the Investor Relations link to the events and presentations page under the Investor News and Event section. Following the call, a replay of the webcast will be archived in the same location.
A press release containing the company's results will be issued on Monday, June 15, 2015, in advance of the conference call and will be accessible on the Company's website in the same location.
Comverse empowers people to engage with each other, services, and things as part of their multi-device, digital lifestyle. We help service providers and enterprises deliver and monetize innovative digital experiences through an award-winning portfolio of software solutions, backed by expert services. Our solutions touch more than two billion people through 450 service providers and enterprises in 125+ countries. You can find us at www.comverse.com.
This press release contains "forward-looking statements," including references to: the Company's intention to complete its quarterly report and announce its financial results within 5 days, the sale of the Company's BSS business, and the ongoing outsourcing of Company employees. Other forward-looking statements can be identified by the use of terminology such as "may," "expects," "plans," "anticipates," "estimates," "believes," "potential," "projects," "forecasts," "intends," or the negative thereof or other comparable terminology. By their very nature, forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results, performance and the timing of events to differ materially from those anticipated, expressed or implied by the forward-looking statements. In this case, the Company may be unable to finish the work necessary to complete its quarterly report and announce its financial results within 5 days as a result of resource constraints, the complexity of the issues presented, or other factors. This release also mentions the pending sale of the Company's BSS business, and ongoing outsourcing of employees, which also pose risks and uncertainties, including the potential inability to complete these transactions or to achieve the benefits expected from them. Other risks and uncertainties affecting the Company are described in the sections entitled "Forward-Looking Statements" and Item 1A, "Risk Factors" and elsewhere in the Company's most recent Annual Report on Form 10-K, or in subsequently filed periodic, current or other reports with the U.S. Securities and Exchange Commission. The Company undertakes no commitment to update or revise any forward-looking statements except as required by law.
CONTACT: Michael Grossi Comverse, Inc. firstname.lastname@example.org +1-781-224-8030NEXT ARTICLE
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...